Status:
COMPLETED
Biliary Excretion of Conjugated Bile Acids in Humans Measured by 11C-cholylsarcosine PET/CT
Lead Sponsor:
University of Aarhus
Conditions:
Cholestasis
Primary Sclerosing Cholangitis
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
We wish to develop a protocol for PET/CT examination of humans using the bile acid tracer 11C-cholylsarcosine. This is done by a series of PET/CT examinations of healthy humans and patients with chole...
Detailed Description
The purpose of the study is the development of PET/CT protocols using 11C-CSar for human use. PET/CT methods developed in the pig studies are translated to studies in healthy humans and patients with ...
Eligibility Criteria
Inclusion
- Patients with cholestatic disorders and healthy subjects
Exclusion
- Body weight above 110 kg (catheterization problematic).
- Diabetes
- Pregnant or breast feeding women.
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT01879735
Start Date
June 1 2013
End Date
September 1 2014
Last Update
February 23 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Nuclear medicine and PET-center
Aarhus, Aarhus C, Denmark, 8000